darumukti.in An Australian clinical study trial has found - TopicsExpress



          

darumukti.in An Australian clinical study trial has found Christchurch-made green shell mussel extract product to be more beneficial for arthritic conditions than glucosamine. A Bromley-based manufacturer sought a 12-week clinical trial involving 38 people undertaken by Queensland University to establish the benefits of their product. “People had been asking us to carry out clinical studies on our product so we went ahead with this significant landmark clinical trial,’’ he said. “The excellent trial results just released to us show that our green shell mussel power works more rapidly and provides faster relief than glucosamine for the arthritis sufferers who took part in the trial. The study proved overwhelming that the green shell mussel extract significantly helped reduce joint pain and increased joint mobility in patients. “This was the result we were looking for and confirms that our green shell mussel product definitely contains significant anti-inflammatory properties.’’ Joint pain is so widespread throughout society and not just the elderly whom suffer from arthritis but also young people, sports people from injuries and many others. The university’s primary clinical investigator in the trial Samantha Coulson confirmed today that the Christchurch green shell mussel powder “worked quicker and provided better relief’’ than the glucosamine used in the trial. New Zealand’s Green Lipped Mussel is Now available in India as Saicra® GLME. Order Today to get Relief from Knee Arthritis and Knee Pain.
Posted on: Thu, 06 Jun 2013 01:59:45 +0000

Trending Topics



Recently Viewed Topics




© 2015